# Inari Medical Inc. (NARI)

Source: https://www.quantisnow.com/company/NARI
Generated: 2026-11-16T07:54:33.876Z

- Ticker: NARI
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Medical/Dental Instruments
- IPO year: 2020
- Website: inarimedical.com

## About

Inari Medical, Inc., a commercial-stage medical device company, focuses on developing products to treat and transform the lives of patients suffering from venous diseases in the United States. It offers ClotTriever for treatment of deep vein thrombosis; and FlowTriever, a thrombectomy system for treatment of pulmonary embolism. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was founded in 2011 and is headquartered in Irvine, California.

## Latest NARI news and filings

- 2025-10-08 12:00 UTC [Calyxo Expands Board of Directors as Number of Patients Treated with its CVAC® System Crosses 20,000 Milestone](https://www.quantisnow.com/insight/calyxo-expands-board-of-directors-as-number-of-patients-treated-6227062)
- 2025-03-03 11:06 UTC [SEC Form 15-12G filed by Inari Medical Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-inari-medical-inc-5918788)
- 2025-02-20 01:26 UTC [SEC Form 4] [Director Warner Robert Keith closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-warner-robert-keith-closing-all-direct-ownership-in-the-5898590)
- 2025-02-20 01:22 UTC [SEC Form 4] [Chief Medical Officer Tu Thomas was granted 7,406 shares, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/chief-medical-officer-tu-thomas-was-granted-7406-shares-closing-5898586)
- 2025-02-20 01:20 UTC [SEC Form 4] [Director Szyman Catherine M. closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-szyman-catherine-m-closing-all-direct-ownership-in-the-5898582)
- 2025-02-20 01:19 UTC [SEC Form 4] [Chief Financial Officer Strange Kevin T closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/chief-financial-officer-strange-kevin-t-closing-all-direct-ownership-5898577)
- 2025-02-20 01:16 UTC [SEC Form 4] [Principal Accounting Officer Silva Karen closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/principal-accounting-officer-silva-karen-closing-all-direct-ownership-in-5898568)
- 2025-02-20 01:14 UTC [SEC Form 4] [Director Root Jonathan D closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-root-jonathan-d-closing-all-direct-ownership-in-the-5898561)
- 2025-02-20 01:07 UTC [SEC Form 4] [Director Milder Donald B closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-milder-donald-b-closing-all-direct-ownership-in-the-5898543)
- 2025-02-20 01:05 UTC [SEC Form 4] [Director Mead Dana G Jr. closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-mead-dana-g-jr-closing-all-direct-ownership-in-5898536)
- 2025-02-20 01:04 UTC [SEC Form 4] [Director Lucchese Cynthia L closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-lucchese-cynthia-l-closing-all-direct-ownership-in-the-5898528)
- 2025-02-20 01:01 UTC [SEC Form 4] [President and CEO Hykes Andrew was granted 20,393 shares, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/president-and-ceo-hykes-andrew-was-granted-20393-shares-closing-5898520)
- 2025-02-20 01:00 UTC [SEC Form 4] [Director Hoffman William closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-hoffman-william-closing-all-direct-ownership-in-the-company-5898516)
- 2025-02-20 00:56 UTC [SEC Form 4] [Director Chambers Rebecca closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-chambers-rebecca-closing-all-direct-ownership-in-the-company-5898510)
- 2025-02-19 14:11 UTC [SEC Form 25-NSE filed by Inari Medical Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-inari-medical-inc-5896020)
- 2025-02-19 14:07 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Inari Medical Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-inari-medical-inc-5896010)
- 2025-02-19 14:04 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Inari Medical Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-inari-medical-inc-5896005)
- 2025-02-19 14:03 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Inari Medical Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-inari-medical-inc-5895993)
- 2025-02-19 14:01 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Inari Medical Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-inari-medical-inc-5895987)
- 2025-02-19 13:59 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Inari Medical Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-inari-medical-inc-5895930)
- 2025-02-19 13:57 UTC [SEC Form POSASR filed by Inari Medical Inc.](https://www.quantisnow.com/insight/sec-form-posasr-filed-by-inari-medical-inc-5895927)
- 2025-02-19 13:55 UTC [SEC Form 8-K] [Inari Medical Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Changes in Control of Registrant, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Leadership Update](https://www.quantisnow.com/insight/inari-medical-inc-filed-sec-form-8-k-notice-of-delisting-5895922)
- 2025-02-19 13:46 UTC [SEC Schedule TOT] [Amendment: SEC Form SC TO-T/A filed by Inari Medical Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-to-ta-filed-by-inari-medical-inc-5895910)
- 2025-02-19 13:45 UTC [SEC Schedule 14D-9] [Amendment: SEC Form SC 14D9/A filed by Inari Medical Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-14d9a-filed-by-inari-medical-inc-5895908)
- 2025-02-19 13:30 UTC [Mergers & Acquisitions] [Stryker completes acquisition of Inari Medical, Inc., providing entry into the high-growth peripheral vascular segment](https://www.quantisnow.com/insight/stryker-completes-acquisition-of-inari-medical-inc-providing-entry-into-5895857)
- 2025-02-14 21:31 UTC [SEC Schedule 14D-9] [Amendment: SEC Form SC 14D9/A filed by Inari Medical Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-14d9a-filed-by-inari-medical-inc-5891111)
- 2025-02-13 22:54 UTC [Leadership Update] [Kadant Set to Join S&P SmallCap 600](https://www.quantisnow.com/insight/kadant-set-to-join-sp-smallcap-600-5888427)
- 2025-02-12 21:42 UTC [SEC Form 4] [President and CEO Hykes Andrew exercised 194,538 shares at a strike of $0.95, increasing direct ownership by 39% to 697,244 units (SEC Form 4)](https://www.quantisnow.com/insight/president-and-ceo-hykes-andrew-exercised-194538-shares-at-a-5885097)
- 2025-02-12 21:38 UTC [SEC Form 4] [Chief Medical Officer Tu Thomas exercised 148,004 shares at a strike of $0.80, increasing direct ownership by 46% to 471,361 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-medical-officer-tu-thomas-exercised-148004-shares-at-a-5885071)
- 2025-02-12 14:58 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Inari Medical Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-inari-medical-inc-5883987)
- 2025-02-07 22:00 UTC [SEC Schedule 14D-9] [Amendment: SEC Form SC 14D9/A filed by Inari Medical Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-14d9a-filed-by-inari-medical-inc-5878103)
- 2025-02-06 21:47 UTC [SEC Form 4] [President and CEO Hykes Andrew was granted 67,282 shares, increasing direct ownership by 15% to 502,706 units (SEC Form 4)](https://www.quantisnow.com/insight/president-and-ceo-hykes-andrew-was-granted-67282-shares-increasing-5876044)
- 2025-02-06 21:45 UTC [SEC Form 4] [Chief Financial Officer Strange Kevin T was granted 21,102 shares, increasing direct ownership by 45% to 67,502 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-financial-officer-strange-kevin-t-was-granted-21102-shares-5876029)
- 2025-02-06 21:42 UTC [SEC Form 4] [Chief Medical Officer Tu Thomas was granted 21,102 shares, increasing direct ownership by 7% to 323,357 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-medical-officer-tu-thomas-was-granted-21102-shares-increasing-5876019)
- 2025-02-06 21:40 UTC [SEC Form 4] [Principal Accounting Officer Silva Karen was granted 5,504 shares, increasing direct ownership by 60% to 14,719 units (SEC Form 4)](https://www.quantisnow.com/insight/principal-accounting-officer-silva-karen-was-granted-5504-shares-increasing-5876007)
- 2025-02-06 21:00 UTC [SEC Schedule 14D-9] [Amendment: SEC Form SC 14D9/A filed by Inari Medical Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-14d9a-filed-by-inari-medical-inc-5875352)
- 2025-02-04 11:04 UTC [SEC Schedule 14D-9] [Amendment: SEC Form SC 14D9/A filed by Inari Medical Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-14d9a-filed-by-inari-medical-inc-5868620)
- 2025-02-04 11:02 UTC [SEC Schedule TOT] [Amendment: SEC Form SC TO-T/A filed by Inari Medical Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-to-ta-filed-by-inari-medical-inc-5868611)
- 2025-01-21 21:00 UTC [Leadership Update] [Masimo Announces Leadership Transition](https://www.quantisnow.com/insight/masimo-announces-leadership-transition-5851858)
- 2025-01-17 21:27 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9 filed by Inari Medical Inc.](https://www.quantisnow.com/insight/sec-form-sc-14d9-filed-by-inari-medical-inc-5850044)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/NARI
- Earnings history: https://www.quantisnow.com/earnings/NARI
- Dividend history: https://www.quantisnow.com/dividends/NARI
- Insider transactions: https://www.quantisnow.com/insiders/NARI
- Options chain: https://www.quantisnow.com/options/NARI
- SEC 8-K filings only: https://www.quantisnow.com/company/NARI/8-k
- RSS and alerts for NARI: https://www.quantisnow.com/docs/rss-feeds.md
